| Product Name | MF | CAS | Details |
|---|
| NAT1 antibody | Details |
| FRETS-25Ile (1 umol) (1umol) | Details |
| trans-2,3-Dimethoxycinnamic Acid | C11H12O4 | 7345-82-6 | Details |
| β-Tocopherol | C28H48O2 | 148-03-8 | Details |
| Methyl (phenyl 2-O-benzoyl-3-O-benzyl-1-thio-a-L-idopyranosyluronate) | C27H26O7S | 616876-73-4 | Details |
| 2-[(Cyclohex-3-en-1-ylmethyl)amino]ethan-1-ol hydrochloride | C9H18ClNO | 1803570-44-6 | Details |
| 1-N-Ethyl-3-(trifluoromethyl)benzene-1,4-diamine | C9H11F3N2 | 1040043-27-3 | Details |
| Diflucortolone | C22H28F2O4 | 2607-06-9 | Details |
| Cytokeratin 84 Blocking Peptide | Details |
| 3-Bromo-2-methylbenzene-1-sulfonamide | C7H8BrNO2S | 1032507-35-9 | Details |
| MIB1 antibody | Details |
| H-Met-His-OH | C11H18N4O3S | 14486-12-5 | Details |
| Diminazene diaceturate | C22H29N9O6 | 908-54-3 | Details |
| 4-Epi-curcumenol | C15H22O2 | 350602-21-0 | Details |
| (2-tert-Butyl-1,3-thiazol-5-yl)methanol | C8H13NOS | 1267558-97-3 | Details |
| N-(4-Aminophenyl)-1,3-dioxaindane-5-carboxamide | C14H12N2O3 | 1593590-12-5 | Details |
| 4-(1,1,2,2,2-Pentafluoroethoxy)benzaldehyde | C9H5F5O2 | 126300-95-6 | Details |
| GMC 2-29 | C29H31N5O3 | 148672-15-5 | Details |
| 3-(1H-1,2,4-Triazol-5-yl)benzoic acid | C9H7N3O2 | 876715-37-6 | Details |
| CBL0137 hydrochloride | C21H25ClN2O2 | 1197397-89-9 | Details |
| Hex-4-yn-1-ol | C6H10O | 928-93-8 | Details |
| trans-β-D-Glucopyranosyl methylacetoacetate | C11H18O8 | 55018-21-8 | Details |
| 1,2,3,4-Tetrahydroquinoline-6-carboxylic acid hydrochloride | C10H12ClNO2 | 1251923-10-0 | Details |
| 3',5'-Di-O-acetyl-5-bromo-2'-deoxyuridine | C13H15BrN2O7 | 6161-23-5 | Details |
| 2-Methyl-5-(methylamino)pyrazine | C6H9N3 | 590423-42-0 | Details |
| Methyl 5-(trifluoromethyl)pyrazole-3-carboxylate | C6H5F3N2O2 | 6833-82-5 | Details |
| N-Dodecyl-B-iminodipropionic acid, disodium | C18H33NNa2O4 | 3655-00-3 | Details |
| 2-(2-Pyridyl)-4-methylthiazole-5-carboxylic acid | C10H8N2O2S | 34418-48-9 | Details |
| H-TAFDEAIAELDTLSEESYK^-OH | Details |
| 3-Methylsalicylic acid | C8H8O3 | 83-40-9 | Details |
| Methyl 2,3,6-tri-O-benzoyl-a-D-glucopyranoside | C28H26O9 | 34234-44-1 | Details |
| PADI4 antibody | Details |
| H-TVF-OH | Details |
| [5-(Morpholin-4-yl)-1,3,4-oxadiazol-2-yl]methanamine | C7H12N4O2 | 1017179-95-1 | Details |
| Methyl 3-O-(a-D-galactopyranosyl)-b-D-galactopyranoside | C13H24O11 | Details |
| N-(2-indol-3-ylethyl)(4-nitrophenyl)formamide | C17H15N3O3 | 33284-07-0 | Details |
| Ac-Thr-Val-Ser-Phe-Asn-Phe-OH trifluoroacetate salt | C36H49N7O11 | 150626-30-5 | Details |
| 1-(Dimethylamino)-6-methyl-3-heptanone | C10H21NO | 107245-26-1 | Details |
| (5-Methyl-1H-indol-2-yl)methanol | C10H11NO | 55795-87-4 | Details |
| 1-(1,4-Dimethylpiperazin-2-yl)ethan-1-amine | C8H19N3 | 1334149-64-2 | Details |
| 4-Bromo-2-(chloromethyl)-1-(difluoromethoxy)benzene | C8H6BrClF2O | 1039329-39-9 | Details |
| Ethyl(pentan-3-yl)amine hydrochloride | C7H18ClN | 151668-06-3 | Details |
| 5-{[(3-Methoxyphenyl)methyl]amino}-2,3-dihydro-1H-1,3-benzodiazol-2-one | C15H15N3O2 | 884993-10-6 | Details |
| 5-Bromo-3-fluoro-2-methoxybenzene-1-sulfonamide | C7H7BrFNO3S | 1303889-98-6 | Details |
| Dapagliflozin Impurity 26 | C29H33ClO10 | 461432-25-7 | Details |
| (+/-)-Perillaldehyde | C10H14O | 2111-75-3 | Details |
| Ethyl 2,2-dimethylpent-4-ynoate | C9H14O2 | 107540-02-3 | Details |
| Ethyl 3-amino-5-(methoxymethyl)benzoate | C11H15NO3 | 1340539-10-7 | Details |
| 2-(1-Ethylcyclobutyl)acetic acid | C8H14O2 | 1439902-62-1 | Details |
| Piracetam-d8 | C6H2D8N2O2 | 1329799-64-5 | Details |
| 2-Hydroxyimipramine b-D-glucuronide | C25H32N2O7 | 54190-76-0 | Details |
| 2H,3H,4H-Pyrano[2,3-c]pyridin-6-amine hydrochloride | C8H11ClN2O | 1909306-37-1 | Details |
| 1-Benzyl-1H-pyrrole-3-carbaldehyde | C12H11NO | 30186-48-2 | Details |
| INHBB antibody | Details |
| Sodium lauryl sulfoacetate | C14H29NaO5S | 1847-58-1 | Details |
| D-Galacturonic acid monohydrate | C6H12O8 | 91510-62-2 | Details |
| 3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid | C11H8ClNO3 | 23598-72-3 | Details |
| Methyl [1,2,4]Triazolo[1,5-a]pyridine-6-carboxylate | C8H7N3O2 | 868362-22-5 | Details |
| N-Methyl-5-phenyl-1H-pyrazol-3-amine | C10H11N3 | 30120-58-2 | Details |
| 1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole | C15H20BNO2 | 884507-19-1 | Details |
| 1-Chloro-2-(chloromethyl)-3-methylbenzene | C8H8Cl2 | 55676-90-9 | Details |
| 4-Ethoxy-3-fluorobenzene-1-sulfonyl chloride | C8H8ClFO3S | 1016756-58-3 | Details |
| 1-(Adamantan-1-yl)imidazolidine-2,4,5-trione | C13H16N2O3 | 37428-73-2 | Details |
| IDR 1002 | C79H130N26O13 | 1224095-25-3 | Details |
| Chlorprothixene hydrochloride | C18H19Cl2NS | 6469-93-8 | Details |
| 4-Methylphenyl cyclopropyl ketone | C11H12O | 7143-76-2 | Details |
| 3-Amino-1-[2-(2,4-dichlorophenyl)ethyl]thiourea | C9H11Cl2N3S | 1152549-09-1 | Details |
| 1-[2-(Propan-2-yloxy)phenyl]propan-1-amine | C12H19NO | 954251-62-8 | Details |
| 6-Propyl-2,3,4,5-tetrahydropyridine | C8H15N | 1604-01-9 | Details |
| Tantalum boride | BTa | 12007-07-7 | Details |
| 5-Isopropyl-3-pyrrolidin-2-ylisoxazole | C10H16N2O | 1018126-16-3 | Details |
| ZNF318 Blocking Peptide | Details |
| 4-(Hydroxymethyl)-1-isopropylpyrrolidin-2-one | C8H15NO2 | 59857-88-4 | Details |
| H-YL^EKALNK-OH | Details |
| (S)-1,2,3,4-Tetrahydro-isoquinoline-3-carboxylic acid amide ee | C10H12N2O | 134732-98-2 | Details |
| Nup53 Antibody | Details |
| Methyl 4-[(2,4-dioxo-1,3-thiazolidin-3-yl)methyl]benzoate | C12H11NO4S | 749216-29-3 | Details |
| FXYD5 antibody | Details |
| Glyburide-d11 | C23H17ClD11N3O5S | 1189985-02-1 | Details |
| 3-[(2-Oxo-2,3-dihydro-1H-indol-3-ylidene)amino]-1-(oxolan-2-ylmethyl)thiourea | C14H16N4O2S | 519152-97-7 | Details |
| 2-(Bromomethyl)-1-(difluoromethoxy)-4-methylbenzene | C9H9BrF2O | 1342768-08-4 | Details |
| BI-3812 | C26H32ClN7O5 | 2166387-64-8 | Details |
| tert-Butyl N-{[1-(aminomethyl)cyclopentyl]methyl}carbamate | C12H24N2O2 | 1548675-07-5 | Details |
| pro-ε-Tx1X/12 | Details |
| 3-Ethyl-5,6-dimethyl-2-sulfanyl-3H,4H-thieno[2,3-d]pyrimidin-4-one | C10H12N2OS2 | 59898-60-1 | Details |
| 2-Bromo-5-methoxy-N,N-dimethylbenzylamine | C10H14BrNO | 10126-37-1 | Details |
| Ethyl 3-methyl-1-(propan-2-yl)-1H-pyrazole-4-carboxylate | C10H16N2O2 | 1321594-80-2 | Details |
| Nantenine | C20H21NO4 | 2565-01-7 | Details |
| RAP1GDS1 antibody | Details |
| RPL11 antibody (FITC) | Details |
| 3-[(5-Cyclopropyl-1,3,4-oxadiazol-2-yl)carbamoyl]propanoic acid | C9H11N3O4 | 1156424-49-5 | Details |
| 2-Chloro-N-{[(3-chlorophenyl)carbamoyl]methyl}-N-methylacetamide | C11H12Cl2N2O2 | 2060063-94-5 | Details |
| H-ISEMFLQIY-OH | Details |
| 2-(3,6-Dihydro-2H-pyran-4-yl)acetic acid | C7H10O3 | 632328-42-8 | Details |
| 2-Methoxy-2-phenylpropane-1-sulfonyl chloride | C10H13ClO3S | 1784362-72-6 | Details |
| 7,8-Dihydro-alpha-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine hydrochloride | C22H25ClF3N | 1622173-72-1 | Details |
| 2-(6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)acetic acid | C13H16O3 | 68254-80-8 | Details |
| 2-Hydroxy-3-(methylsulfanyl)propanoic acid | C4H8O3S | 15592-42-4 | Details |
| (3-[1,2,4]Triazolo[4,3-a]pyridin-3-ylpropyl)amine dihydrochloride | C9H13ClN4 | 1949815-72-8 | Details |
| 5,2'-Dihydroxyflavone | C15H10O4 | 6674-39-1 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||